IL139385A - Labelled glutamine and lysine analogues, metal complexes thereof, and uses thereof for diagnosis - Google Patents

Labelled glutamine and lysine analogues, metal complexes thereof, and uses thereof for diagnosis

Info

Publication number
IL139385A
IL139385A IL13938599A IL13938599A IL139385A IL 139385 A IL139385 A IL 139385A IL 13938599 A IL13938599 A IL 13938599A IL 13938599 A IL13938599 A IL 13938599A IL 139385 A IL139385 A IL 139385A
Authority
IL
Israel
Prior art keywords
diagnosis
metal complexes
labelled
glutamine
lysine analogues
Prior art date
Application number
IL13938599A
Other languages
English (en)
Other versions
IL139385A0 (en
Original Assignee
Amersham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Plc filed Critical Amersham Plc
Publication of IL139385A0 publication Critical patent/IL139385A0/xx
Publication of IL139385A publication Critical patent/IL139385A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL13938599A 1998-05-15 1999-05-14 Labelled glutamine and lysine analogues, metal complexes thereof, and uses thereof for diagnosis IL139385A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98303872 1998-05-15
PCT/GB1999/001550 WO1999060018A1 (en) 1998-05-15 1999-05-14 Labelled glutamine and lysine analogues

Publications (2)

Publication Number Publication Date
IL139385A0 IL139385A0 (en) 2001-11-25
IL139385A true IL139385A (en) 2005-09-25

Family

ID=8234827

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13938599A IL139385A (en) 1998-05-15 1999-05-14 Labelled glutamine and lysine analogues, metal complexes thereof, and uses thereof for diagnosis

Country Status (17)

Country Link
US (2) US7049289B1 (de)
EP (1) EP1077998B1 (de)
JP (2) JP4199420B2 (de)
KR (1) KR100660509B1 (de)
CN (2) CN1309661A (de)
AT (1) ATE384075T1 (de)
AU (1) AU762736B2 (de)
BR (1) BR9910468A (de)
CA (1) CA2332277A1 (de)
DE (1) DE69937996T2 (de)
ES (1) ES2299245T3 (de)
HU (1) HUP0102154A3 (de)
IL (1) IL139385A (de)
NO (1) NO20005751L (de)
RU (1) RU2205186C2 (de)
WO (1) WO1999060018A1 (de)
ZA (1) ZA200006313B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1379885A4 (de) * 2001-01-05 2005-07-06 Univ Duke Kontrastverstärkungsmittel für die magnetresonanzabbildung
GB0116815D0 (en) * 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates
HU230901B1 (hu) * 2001-07-10 2019-01-28 Ge Healthcare Limited Peptidalapú vegyületek és ezeket tartalmazó gyógyszerkészítmények
GB0223249D0 (en) * 2002-10-08 2002-11-13 Amersham Plc Improved imaging agents
GB0224799D0 (en) * 2002-10-25 2002-12-04 Amersham Plc Improved complex compositions
US20070184537A1 (en) * 2003-06-03 2007-08-09 Paul Scherrer Institut Method for the linkage of bifunctional chelating agents and (radioactive) transition metal complexes to proteins and peptides
GB0515974D0 (en) * 2005-08-03 2005-09-07 Ge Healthcare Ltd Compounds and imaging methods
WO2007063824A1 (ja) * 2005-11-29 2007-06-07 Nihon Medi-Physics Co., Ltd. 放射性ハロゲン標識有機化合物の前駆体化合物
WO2008060368A2 (en) * 2006-10-02 2008-05-22 Duke University Transglutaminase-binding peptides and methods of use
US20130195756A1 (en) 2012-01-31 2013-08-01 General Electric Company 99mTc IMAGING AGENTS AND METHODS OF USE
US10610608B2 (en) 2013-08-01 2020-04-07 Rochester Institute Of Technology Modular imaging agents containing amino acids and peptides
GB201610176D0 (en) * 2016-06-10 2016-07-27 Edinburgh Molecular Imaging Ltd Imaging agents and methods of use
EP3538093B1 (de) * 2016-11-09 2023-10-25 Qiagen Sciences, LLC Photoprotektive mischungen als bildgebungsreagenzien bei der sequenzierung durch synthese

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041023A (en) * 1976-04-14 1977-08-09 Hoffmann-La Roche Inc. Labelled peptides
JPS59186947A (ja) * 1983-03-09 1984-10-23 Kowa Co 新規ペプチド
AU2258788A (en) * 1987-07-07 1989-01-30 Cytrx Biopool Ltd. Fibrin-binding compound and method
US5270030A (en) * 1988-12-29 1993-12-14 Bio-Technology General Corp. Fibrin binding domain polypeptide and method of producing
EP0629133B1 (de) * 1992-01-03 2000-11-29 Rhomed, Incorporated Pharmazeutische anwendungen auf der basis von peptid-metall-ionen
US5608110A (en) * 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
US6653299B1 (en) * 1997-01-21 2003-11-25 Nycomed Amersham Plc Labelled factor XIIIa substrates

Also Published As

Publication number Publication date
WO1999060018A1 (en) 1999-11-25
DE69937996D1 (de) 2008-03-06
JP2002515510A (ja) 2002-05-28
AU762736B2 (en) 2003-07-03
CN1309661A (zh) 2001-08-22
KR100660509B1 (ko) 2006-12-22
RU2205186C2 (ru) 2003-05-27
AU3942899A (en) 1999-12-06
ZA200006313B (en) 2002-07-17
NO20005751L (no) 2001-01-08
NO20005751D0 (no) 2000-11-14
BR9910468A (pt) 2001-01-09
IL139385A0 (en) 2001-11-25
CN101407543A (zh) 2009-04-15
CA2332277A1 (en) 1999-11-25
EP1077998B1 (de) 2008-01-16
ES2299245T3 (es) 2008-05-16
US7049289B1 (en) 2006-05-23
DE69937996T2 (de) 2009-01-02
JP4199420B2 (ja) 2008-12-17
US20060292075A1 (en) 2006-12-28
HUP0102154A3 (en) 2009-01-28
HUP0102154A2 (hu) 2001-09-28
EP1077998A1 (de) 2001-02-28
ATE384075T1 (de) 2008-02-15
KR20010043608A (ko) 2001-05-25
JP2006137751A (ja) 2006-06-01

Similar Documents

Publication Publication Date Title
IL139385A0 (en) Labelled glutamine and lysine analogues
US5889009C1 (en) Method of inhibiting cell adhesion
ZA933461B (en) Dual action inhibitors
LV11430A (lv) 2-Piridilmetilenpoliazamakrociklofosfonskabes to kompleksi un atvasinajumi izmantosanai par kontrastvielam
AU8188987A (en) Improved metal complex-containing pharmaceutical agents
GEP20074185B (en) Incclusion complexs of aryl- heterocyclic salts
HN1996000082A (es) Compuestos de quinolina y quinozssolina utiles en terapia.
BG101851A (en) Hepatitis vaccine
MY114688A (en) Lubricating composition including an ester-use of the composition and well fluid including the composition
IL133883A0 (en) Directed cytolysis of target cells, agents and compositions causing cytolysis, and compounds that can be used to produce the agents
FI955851L (fi) Synergistisesti stabiloituja nestemäisiä entsymaattisia koostumuksia
ZA986532B (en) Benefit agent compositions comprising mixtures of alpha-hydroxy esters.
SG168401A1 (en) Catalyst and use thereof
NZ334854A (en) Foliar fertilisers including trace element compounds
IL148971A0 (en) Carbon monoxide source for preparation of transition-metal-carbonyl-complexer
TW349000B (en) Fungicidal two-component composition based on R-metalaxyl and usage thereof
CA2186669A1 (en) Pest-controlling composition
CZ15599A3 (cs) Barevná kompozice obsahující činidlo tvořené pyrogallolovými entitami, železnatou solí a organickou kyselinou
DE59808546D1 (de) Verwendung von fettsäureniedrigalkylestern in abbeizmitteln
BG104119A (en) A new composition
WO1998031399A3 (en) Labelled factor xiiia substrates
GB0007465D0 (en) Substrate for a lipase enzyme assay
GB2411656B (en) Ester slip agents
DE59807141D1 (de) Polyrotaxane
EP0884378A3 (de) Reibungsmodifizierende Verbindung und diese enthaltende Schmierölzusammensetzung

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees